← Leaderboards
Dorothy K Hatsukami
University Of Minnesota Twin Cities
$58,862,572
Attributed
$65,255,795
Total exposure
36
Grants
27
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $29M · FY2005–25$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$172,606,394 · 40
By mechanism
U54$92,828,200 · 4
P01$22,668,793 · 8
U19$19,812,084 · 4
P50$18,425,585 · 2
R01$14,728,196 · 8
U01$2,472,567 · 2
Top collaborators
- Eric Christian Donny19 shared
- Peter G. Shields11 shared
- Irina Stepanov10 shared
- Stephen S Hecht5 shared
- Thomas William Molitor2 shared
- Jian-Min Yuan1 shared
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- Fung-Lung Chung$13,183,556
- Sharon E Murphy$7,347,364
Others in their field
Top investigators on “Tobacco”
- Gregory D Peterson · University Of Tennessee Knoxville$84,527,696
- Lloyd D Johnston · University Of Michigan At Ann Arbor$67,097,167
- Richard A Miech · Johns Hopkins University$51,772,192
- Stephen T Higgins · University Of Vermont &St Agric College$45,191,145
- Stephen S Hecht · University Of Minnesota$41,546,048
- Caryn Lerman · University Of Southern California$34,135,528
Research focus
TobaccoNicotineSmokerCigaretteSmokingClinical TrialsBiological MarkersExposure ToResearch PersonnelBasePerceptionTobacco ControlUnited States Food And Drug AdministrationToxic EffectAreaAffectSciencePoliciesResponseSmokeDependenceRegulationEvaluationTobacco Use
Grant awards (166)
Core B. Clinical & Biomarkers Core$688,272
P01 · FY2025 · CA · contact PI
Core B. Clinical & Biomarkers Core$656,005
P01 · FY2024 · CA · contact PI
Core B. Clinical & Biomarkers Core$642,684
P01 · FY2023 · CA · contact PI
Evaluating New Nicotine Standards for Cigarettes$2,857,780
U54 · FY2022 · DA
Consortium on Methods Evaluating Tobacco (COMET): FilterVentilation and Product Standards$1,331,729
P01 · FY2022 · CA · contact PI
Evaluating New Nicotine Standards for Cigarettes - Project 1$742,453
U54 · FY2022 · DA · contact PI
Clinical Trial of Watercress in Detoxification of Environmental Toxicants and Carcinogens$613,074
R01 · FY2022 · CA
Core B. Clinical & Biomarkers Core$573,303
P01 · FY2022 · CA · contact PI
Impact of sugars on tobacco product toxicity and abuse liability$421,132
R01 · FY2022 · DA
Evaluating New Nicotine Standards for Cigarettes$322,061
U54 · FY2022 · DA
Summer Research Program for Diversity Students in PharmacoNeuroImmunology$107,979
R25 · FY2022 · DA
Consortium on Methods Evaluating Tobacco (COMET): FilterVentilation and Product Standards$2,488,501
P01 · FY2021 · CA · contact PI
Clinical Trial of Watercress in Detoxification of Environmental Toxicants and Carcinogens$638,969
R01 · FY2021 · CA
Project 1: Effects of unventilated filters on pattern of cigarette use, toxicant exposure and uptake of alternative nicotine products$482,099
P01 · FY2021 · CA · contact PI
Impact of sugars on tobacco product toxicity and abuse liability$431,405
R01 · FY2021 · DA
Core A: Administrative Core$305,455
P01 · FY2021 · CA · contact PI
Summer Research Program for Diversity Students in PharmacoNeuroImmunology$107,979
R25 · FY2021 · DA
Evaluating New Nicotine Standards for Cigarettes$4,409,415
U54 · FY2020 · DA
Consortium on Methods Evaluating Tobacco (COMET): FilterVentilation and Product Standards$2,497,158
P01 · FY2020 · CA · contact PI
Evaluating New Nicotine Standards for Cigarettes - Project 1$1,770,866
U54 · FY2020 · DA · contact PI
Project 1: Effects of unventilated filters on pattern of cigarette use, toxicant exposure and uptake of alternative nicotine products$720,466
P01 · FY2020 · CA · contact PI
Clinical Trial of Watercress in Detoxification of Environmental Toxicants and Carcinogens$639,083
R01 · FY2020 · CA
Impact of sugars on tobacco product toxicity and abuse liability$437,383
R01 · FY2020 · DA
Core A: Administrative Core$283,171
P01 · FY2020 · CA · contact PI
Core B - The Clinical and Biomarkers Core$272,404
P01 · FY2020 · CA · contact PI
Evaluating New Nicotine Standards for Cigarettes$4,421,280
U54 · FY2019 · DA
Consortium on Methods Evaluating Tobacco (COMET): FilterVentilation and Product Standards$2,291,226
P01 · FY2019 · CA · contact PI
Evaluating New Nicotine Standards for Cigarettes - Project 1$1,766,160
U54 · FY2019 · DA · contact PI
Project 1: Effects of unventilated filters on pattern of cigarette use, toxicant exposure and uptake of alternative nicotine products$687,505
P01 · FY2019 · CA · contact PI
Clinical Trial of Watercress in Detoxification of Environmental Toxicants and Carcinogens$617,370
R01 · FY2019 · CA
Core B - The Clinical and Biomarkers Core$266,252
P01 · FY2019 · CA · contact PI
Core A: Administrative Core$255,200
P01 · FY2019 · CA · contact PI
Evaluating New Nicotine Standards for Cigarettes$4,513,522
U54 · FY2018 · DA
Evaluating New Nicotine Standards for Cigarettes - Project 1$1,806,361
U54 · FY2018 · DA · contact PI
Consortium on Methods Evaluating Tobacco (COMET): FilterVentilation and Product Standards$1,197,947
P01 · FY2018 · CA · contact PI
Core B - The Clinical and Biomarkers Core$626,055
P01 · FY2018 · CA · contact PI
Clinical Trial of Watercress in Detoxification of Environmental Toxicants and Carcinogens$612,664
R01 · FY2018 · CA
Biomarkers of exposure and effect in SREC users$586,005
U01 · FY2018 · DA
Project 1: Effects of unventilated filters on pattern of cigarette use, toxicant exposure and uptake of alternative nicotine products$356,409
P01 · FY2018 · CA · contact PI
Core A: Administrative Core$141,798
P01 · FY2018 · CA · contact PI
Evaluating New Nicotine Standards for Cigarettes$3,471,615
U54 · FY2017 · DA
Consortium on Methods Evaluating Tobacco (COMET): FilterVentilation and Product Standards$2,796,778
P01 · FY2017 · CA · contact PI
Evaluating New Nicotine Standards for Cigarettes - Project 1$1,211,110
U54 · FY2017 · DA · contact PI
Core B - The Clinical and Biomarkers Core$666,961
P01 · FY2017 · CA · contact PI
Biomarkers of exposure and effect in SREC users$580,975
U01 · FY2017 · DA
Program Integration and Management$399,541
P01 · FY2017 · CA · contact PI
Project 1: Effects of unventilated filters on pattern of cigarette use, toxicant exposure and uptake of alternative nicotine products$399,540
P01 · FY2017 · CA · contact PI
Core A: Administrative Core$399,539
P01 · FY2017 · CA · contact PI
Clinical Trial Method for Assessing a Tobacco Product$2,214,466
U19 · FY2016 · CA · contact PI
Models For Tobacco Product Evaluation$2,214,466
U19 · FY2016 · CA · contact PI
Core B - The Clinical and Biomarkers Core$481,241
P01 · FY2016 · CA · contact PI
Evaluating New Nicotine Standards for Cigarettes$12,546,088
U54 · FY2015 · DA
Models For Tobacco Product Evaluation$2,634,102
U19 · FY2015 · CA · contact PI
STRATEGIES FOR REDUCING NICOTINE CONTENT IN CIGARETTES$2,542,748
U54 · FY2015 · DA · contact PI
ADMINISTRATIVE CORE$2,204,916
U54 · FY2015 · DA
Clinical Trial Method for Assessing a Tobacco Product$746,973
U19 · FY2015 · CA · contact PI
Administrative and Policy Core$268,180
U19 · FY2015 · CA · contact PI
Evaluating New Nicotine Standards for Cigarettes$14,046,199
U54 · FY2014 · DA
STRATEGIES FOR REDUCING NICOTINE CONTENT IN CIGARETTES$9,647,070
U54 · FY2014 · DA · contact PI
Models For Tobacco Product Evaluation$2,563,112
U19 · FY2014 · CA · contact PI
ADMINISTRATIVE CORE$1,486,613
U54 · FY2014 · DA
Clinical Trial Method for Assessing a Tobacco Product$768,720
U19 · FY2014 · CA · contact PI
Administrative and Policy Core$221,426
U19 · FY2014 · CA · contact PI
Metabolism of NNK among African Americans$121,382
P01 · FY2014 · CA · contact PI
Novel Determinants and Measures of Smokeless Tobacco Use$95,060
R01 · FY2014 · CA · contact PI
University of Minnesota (UMINN) Clinical Trial Site$79,116
U01 · FY2014 · DA · contact PI
Evaluating New Nicotine Standards for Cigarettes$7,142,414
U54 · FY2013 · DA
Models For Tobacco Product Evaluation$3,205,996
U19 · FY2013 · CA · contact PI
Evaluating New Nicotine Standards for Cigarettes$3,072,358
U54 · FY2013 · DA
Evaluating New Nicotine Standards for Cigarettes$2,744,244
U54 · FY2013 · DA
STRATEGIES FOR REDUCING NICOTINE CONTENT IN CIGARETTES$1,112,297
U54 · FY2013 · DA · contact PI
Clinical Trial Method for Assessing a Tobacco Product$952,140
U19 · FY2013 · CA · contact PI
ADMINISTRATIVE CORE$623,936
U54 · FY2013 · DA
STRATEGIES FOR REDUCING NICOTINE CONTENT IN CIGARETTES$592,025
U54 · FY2013 · DA · contact PI
Novel Determinants and Measures of Smokeless Tobacco Use$449,810
R01 · FY2013 · CA · contact PI
Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers$387,979
R01 · FY2013 · CA · contact PI
ADMINISTRATIVE CORE$380,826
U54 · FY2013 · DA
Administrative and Policy Core$278,593
U19 · FY2013 · CA · contact PI
Metabolism of NNK among African Americans$176,304
P01 · FY2013 · CA · contact PI
University of Minnesota (UMINN) Clinical Trial Site$169,664
U01 · FY2013 · DA · contact PI
Program Leadership$154,603
P30 · FY2013 · CA · contact PI
Prevention & Etiology$73,955
P30 · FY2013 · CA · contact PI
Models For Tobacco Product Evaluation$2,652,358
U19 · FY2012 · CA · contact PI
Evaluating New Nicotine Standards for Cigarettes$2,612,355
U54 · FY2012 · DA
STRATEGIES FOR REDUCING NICOTINE CONTENT IN CIGARETTES$1,017,525
U54 · FY2012 · DA · contact PI
Clinical Trial Method for Assessing a Tobacco Product$870,270
U19 · FY2012 · CA · contact PI
Randomized trial of PEITC as a modifier of NNK metabolism in smokers$542,156
R01 · FY2012 · CA
Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers$525,318
R01 · FY2012 · CA · contact PI
Novel Determinants and Measures of Smokeless Tobacco Use$403,012
R01 · FY2012 · CA · contact PI
ADMINISTRATIVE CORE$393,083
U54 · FY2012 · DA
University of Minnesota (UMINN) Clinical Trial Site$329,040
U01 · FY2012 · DA · contact PI
Administrative and Policy Core$221,282
U19 · FY2012 · CA · contact PI
Program Leadership$197,149
P30 · FY2012 · CA · contact PI
Metabolism of NNK among African Americans$132,763
P01 · FY2012 · CA · contact PI
University of Minnesota (UMINN) Clinical Trial Site$103,200
U01 · FY2012 · DA · contact PI
SYSTEMIC DATA COLLECTION GLOBAL TOBACCO CONTROL AND PREVENTION N$50,000
N02 · FY2012 · CA · contact PI
Prevention & Etiology$30,107
P30 · FY2012 · CA · contact PI
Program Leadership$2,680
P30 · FY2012 · CA · contact PI
Prevention & Etiology$2,679
P30 · FY2012 · CA · contact PI
Prevention & Etiology$1,776
P30 · FY2012 · CA · contact PI
Program Leadership$1,776
P30 · FY2012 · CA · contact PI
Evaluating New Nicotine Standards for Cigarettes$2,537,775
U54 · FY2011 · DA
ADMINISTRATIVE CORE$599,344
U54 · FY2011 · DA
Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers$547,043
R01 · FY2011 · CA · contact PI
Novel Determinants and Measures of Smokeless Tobacco Use$522,474
R01 · FY2011 · CA · contact PI
University of Minnesota (UMINN) Clinical Trial Site$335,211
U01 · FY2011 · DA · contact PI
STRATEGIES FOR REDUCING NICOTINE CONTENT IN CIGARETTES$233,761
U54 · FY2011 · DA · contact PI
Program Leadership$219,383
P30 · FY2011 · CA · contact PI
Metabolism of NNK among African Americans$185,855
P01 · FY2011 · CA · contact PI
Support services for the Tobacco Harm Reduction Network$49,652
N02 · FY2011 · CA · contact PI
Prevention & Etiology$33,501
P30 · FY2011 · CA · contact PI
Novel Determinants and Measures of Smokeless Tobacco Use$559,824
R01 · FY2010 · CA · contact PI
Innovative Interventions for Smoking Cessation$466,186
R01 · FY2010 · DA · contact PI
University of Minnesota (UMINN) Clinical Trial Site$289,356
U01 · FY2010 · DA · contact PI
Program Leadership$235,379
P30 · FY2010 · CA · contact PI
Novel Determinants and Measures of Smokeless Tobacco Use$199,846
R01 · FY2010 · CA · contact PI
Metabolism of NNK among African Americans$145,250
P01 · FY2010 · CA · contact PI
Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers$51,431
R01 · FY2010 · CA · contact PI
TOBACCO HARM REDUCTION NETWORK (THRN).$49,984
N02 · FY2010 · CA · contact PI
Prevention & Etiology$35,942
P30 · FY2010 · CA · contact PI
Novel Determinants and Measures of Smokeless Tobacco Use$580,454
R01 · FY2009 · CA · contact PI
Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers$571,855
R01 · FY2009 · CA · contact PI
Innovative Interventions for Smoking Cessation$457,949
R01 · FY2009 · DA · contact PI
Program Leadership$228,695
P30 · FY2009 · CA · contact PI
Prevention & Etiology$34,923
P30 · FY2009 · CA · contact PI
SMOKELESS TOBACCO PRODUCTS VS MEDICINAL NICOTINE: PHARMACOKINETICS AND PHARMACO$14,636
M01 · FY2009 · RR · contact PI
Tobacco Exposure Reduction$1,812,363
P50 · FY2008 · DA · contact PI
Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers$570,659
R01 · FY2008 · CA · contact PI
Project 3: Methods for tobacco exposure reduction in humans$359,493
P50 · FY2008 · DA · contact PI
Tobacco Exposure Reduction$125,000
P50 · FY2008 · DA · contact PI
Treatment of Smokeless Tobacco Users$36,540
R01 · FY2008 · DA · contact PI
SMOKELESS TOBACCO PRODUCTS VS MEDICINAL NICOTINE: PHARMACOKINETICS AND PHARMACO$7,510
M01 · FY2008 · RR · contact PI
THE EFFECT OF NIC VAX ON PHARMACOKINETICS AND SUBJECTIVE EFFECTS OF NICOTINE$3,534
M01 · FY2008 · RR · contact PI
Tobacco Exposure Reduction$1,799,605
P50 · FY2007 · DA · contact PI
Project 3: Methods for tobacco exposure reduction in humans$424,120
P50 · FY2007 · DA · contact PI
Tobacco Exposure Reduction$224,250
P50 · FY2007 · DA · contact PI
THE EFFECT OF NIC VAX ON PHARMACOKINETICS AND SUBJECTIVE EFFECTS OF NICOTINE$5,985
M01 · FY2007 · RR · contact PI
Tobacco Exposure Reduction$1,801,750
P50 · FY2006 · DA · contact PI
Project 3: Methods for tobacco exposure reduction in humans$343,118
P50 · FY2006 · DA · contact PI
TSNA EXPOSURE FROM CIGARETTES WITH DIFFERING TSNA CONTENT IN SMOKE$21,162
M01 · FY2006 · RR · contact PI
Tobacco Exposure Reduction$1,800,293
P50 · FY2005 · DA
Project 3: Methods for tobacco exposure reduction in humans$264,496
P50 · FY2005 · DA
Treatment of Smokeless Tobacco Users$260,476
R01 · FY2005 · DA
Interventions for Tobacco Dependent Adolescents$191,459
R01 · FY2005 · DA
Tobacco Exposure Reduction$1,750,000
P50 · FY2004 · DA
Interventions for Tobacco Dependent Adolescents$385,497
R01 · FY2004 · DA
Treatment of Smokeless Tobacco Users$364,432
R01 · FY2004 · DA
Project 3: Methods for tobacco exposure reduction in humans$254,238
P50 · FY2004 · DA
TOBACCO EXPOSURE REDUCTION$1,804,099
P50 · FY2003 · DA
Treatment of Smokeless Tobacco Users$384,572
R01 · FY2003 · DA
Interventions for Tobacco Dependent Adolescents$359,026
R01 · FY2003 · DA
TOBACCO EXPOSURE REDUCTION$1,860,859
P50 · FY2002 · DA
Interventions for Tobacco Dependent Adolescents$369,591
R01 · FY2002 · DA
Treatment of Smokeless Tobacco Users$317,620
R01 · FY2002 · DA
TOBACCO EXPOSURE REDUCTION$52,383
P50 · FY2002 · DA
STRESS HORMONES &STIMULANT USE IN HUMANS$0
M01 · FY2002 · RR
VACCINATION FOR TREATMENT OF NICOTINE DEPENDENCE$0
U19 · FY2002 · DA
STRESS HORMONES &STIMULANT USE IN HUMANS$0
M01 · FY2002 · RR
TOBACCO EXPOSURE REDUCTION$1,864,489
P50 · FY2001 · DA
Interventions for Tobacco Dependent Adolescents$387,951
R01 · FY2001 · DA
Treatment of Smokeless Tobacco Users$328,896
R01 · FY2001 · DA
VACCINATION FOR TREATMENT OF NICOTINE DEPENDENCE$0
U19 · FY2001 · DA
STRESS HORMONES &STIMULANT USE IN HUMANS$0
M01 · FY2001 · RR
TOBACCO EXPOSURE REDUCTION$1,885,029
P50 · FY2000 · DA
VACCINATION FOR TREATMENT OF NICOTINE DEPENDENCE$0
U19 · FY2000 · DA
STRESS HORMONES &STIMULANT USE IN HUMANS$0
M01 · FY2000 · RR